Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Public Opinion and Sentiment Before and at the Beginning of COVID-19 Vaccinations in Japan: Twitter Analysis

View ORCID ProfileQian Niu, View ORCID ProfileJunyu Liu, Masaya Kato, Yuki Shinohara, Natsuki Matsumura, Tomoki Aoyama, View ORCID ProfileMomoko Nagai-Tanima
doi: https://doi.org/10.1101/2021.07.19.21260735
Qian Niu
1Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Qian Niu
Junyu Liu
2Department of Intelligence Science and Technology, Graduate School of Informatics, Kyoto University, Kyoto, Japan
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Junyu Liu
Masaya Kato
1Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuki Shinohara
1Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natsuki Matsumura
1Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomoki Aoyama
1Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Momoko Nagai-Tanima
1Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan
PT, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Momoko Nagai-Tanima
  • For correspondence: tanima.momoko.8s{at}kyoto-u.ac.jp
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The global public health and socioeconomic impacts of COVID-19 have been substantial. To achieve herd immunity, widespread use of the vaccine is required, and it is therefore critical for government and public health agencies to understand public perceptions of the vaccine to help sustain subsequent vaccinations.

Objective This study aims to explore the opinions and sentiments of tweets about COVID-19 vaccination among Twitter users in Japan, both before and at the beginning of the COVID-19 vaccination program.

Methods We collected 144,101 Japanese tweets containing COVID-19 vaccine-related keywords from Japanese Twitter users between August 1, 2020, and June 30, 2021. Specifically, we identified temporal changes in the number of tweets and key events that triggered a surge in the number of tweets. In addition, we performed sentiment analysis, and calculated the correlation between different sentiments and the number of deaths, infections, and vaccinations. We also built latent Dirichlet allocation (LDA) topic models to identify commonly discussed topics in a large sample of tweets. We also provided a word cloud of high-frequency unigram and bigram tokens as additional evidence, and conducted further analysis on three different vaccine brands.

Results The overall number of tweets has continued to increase since the start of mass vaccination in Japan. Sentiments were generally neutral, but negative sentiment was more significant than positive sentiment. Before and after the first vaccination in Japan, the correlations of negative/positive sentiment with death, infection, and vaccination cases changed significantly. Public concerns revolved around three themes: information on vaccine reservations and vaccinations in Japan; infection and mutation of COVID-19 in Japan; and prevention measures, vaccine development and supply, and vaccination status in other countries. Furthermore, public attention to the three brands of vaccines has a temporal shift as clinical trials move forward.

Conclusions The number of tweets and changes in sentiment might be driven by major news events in relation to the COVID-19 vaccine, with negative sentiments dominating positive sentiments overall. Death and infection cases correlated significantly with negative sentiments, but the correlation fell after vaccinations began as morbidity and mortality decreased. The public’s attention to different vaccine brands had a temporal change during their clinical trial process, and although the discussion points are slightly different, the core remains effective and secure.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The authors received no specific funding for this work.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Kyoto University,Japan

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The authors provided all the raw datasets as supporting information to replicate our study findings.

http://www.panacealab.org/covid19/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted July 22, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Public Opinion and Sentiment Before and at the Beginning of COVID-19 Vaccinations in Japan: Twitter Analysis
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Public Opinion and Sentiment Before and at the Beginning of COVID-19 Vaccinations in Japan: Twitter Analysis
Qian Niu, Junyu Liu, Masaya Kato, Yuki Shinohara, Natsuki Matsumura, Tomoki Aoyama, Momoko Nagai-Tanima
medRxiv 2021.07.19.21260735; doi: https://doi.org/10.1101/2021.07.19.21260735
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Public Opinion and Sentiment Before and at the Beginning of COVID-19 Vaccinations in Japan: Twitter Analysis
Qian Niu, Junyu Liu, Masaya Kato, Yuki Shinohara, Natsuki Matsumura, Tomoki Aoyama, Momoko Nagai-Tanima
medRxiv 2021.07.19.21260735; doi: https://doi.org/10.1101/2021.07.19.21260735

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Informatics
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)